vs
Cytek Biosciences, Inc.(CTKB)与Repay Holdings Corp(RPAY)财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是Cytek Biosciences, Inc.的1.3倍($78.6M vs $62.1M),Cytek Biosciences, Inc.净利率更高(-70.9% vs -178.3%,领先107.4%),Cytek Biosciences, Inc.同比增速更快(8.1% vs 0.4%),Repay Holdings Corp自由现金流更多($23.2M vs $-1.8M),过去两年Cytek Biosciences, Inc.的营收复合增速更高(17.7% vs -1.3%)
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化,产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域,客户遍及全球多个主要地区。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商,为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案,涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具,助力客户简化交易流程、提升运营效率。
CTKB vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.3倍
$62.1M
营收增速更快
CTKB
高出7.7%
0.4%
净利率更高
CTKB
高出107.4%
-178.3%
自由现金流更多
RPAY
多$25.0M
$-1.8M
两年增速更快
CTKB
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $62.1M | $78.6M |
| 净利润 | $-44.1M | $-140.1M |
| 毛利率 | 52.9% | 74.2% |
| 营业利润率 | -9.0% | -182.2% |
| 净利率 | -70.9% | -178.3% |
| 营收同比 | 8.1% | 0.4% |
| 净利润同比 | -557.1% | -3304.1% |
| 每股收益(稀释后) | — | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CTKB
RPAY
| Q4 25 | $62.1M | $78.6M | ||
| Q3 25 | $52.3M | $77.7M | ||
| Q2 25 | $45.6M | $75.6M | ||
| Q1 25 | $41.5M | $77.3M | ||
| Q4 24 | $57.5M | $78.3M | ||
| Q3 24 | $51.5M | $79.1M | ||
| Q2 24 | $46.6M | $74.9M | ||
| Q1 24 | $44.9M | $80.7M |
净利润
CTKB
RPAY
| Q4 25 | $-44.1M | $-140.1M | ||
| Q3 25 | $-5.5M | $-6.4M | ||
| Q2 25 | $-5.6M | $-102.3M | ||
| Q1 25 | $-11.4M | $-7.9M | ||
| Q4 24 | $9.6M | $-4.1M | ||
| Q3 24 | $941.0K | $3.2M | ||
| Q2 24 | $-10.4M | $-4.1M | ||
| Q1 24 | $-6.2M | $-5.2M |
毛利率
CTKB
RPAY
| Q4 25 | 52.9% | 74.2% | ||
| Q3 25 | 52.7% | 74.4% | ||
| Q2 25 | 52.3% | 75.7% | ||
| Q1 25 | 48.6% | 75.9% | ||
| Q4 24 | 58.5% | 76.3% | ||
| Q3 24 | 56.3% | 77.8% | ||
| Q2 24 | 54.6% | 78.2% | ||
| Q1 24 | 51.3% | 76.2% |
营业利润率
CTKB
RPAY
| Q4 25 | -9.0% | -182.2% | ||
| Q3 25 | -17.6% | -3.9% | ||
| Q2 25 | -23.3% | -138.7% | ||
| Q1 25 | -36.1% | -4.7% | ||
| Q4 24 | 5.2% | -1.5% | ||
| Q3 24 | -8.2% | -0.9% | ||
| Q2 24 | -18.3% | -4.6% | ||
| Q1 24 | -23.9% | -3.1% |
净利率
CTKB
RPAY
| Q4 25 | -70.9% | -178.3% | ||
| Q3 25 | -10.5% | -8.3% | ||
| Q2 25 | -12.2% | -135.2% | ||
| Q1 25 | -27.5% | -10.3% | ||
| Q4 24 | 16.8% | -5.3% | ||
| Q3 24 | 1.8% | 4.1% | ||
| Q2 24 | -22.4% | -5.4% | ||
| Q1 24 | -13.8% | -6.5% |
每股收益(稀释后)
CTKB
RPAY
| Q4 25 | — | $-1.68 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-1.15 | ||
| Q1 25 | — | $-0.09 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $341.7M | $484.4M |
| 总资产 | $461.5M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势,按日历期对齐
现金及短期投资
CTKB
RPAY
| Q4 25 | $90.9M | $115.7M | ||
| Q3 25 | $93.3M | $95.7M | ||
| Q2 25 | $75.5M | $162.6M | ||
| Q1 25 | $95.3M | $165.5M | ||
| Q4 24 | $98.7M | $189.5M | ||
| Q3 24 | $162.3M | $168.7M | ||
| Q2 24 | $177.9M | $147.1M | ||
| Q1 24 | $168.8M | $128.3M |
总债务
CTKB
RPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
股东权益
CTKB
RPAY
| Q4 25 | $341.7M | $484.4M | ||
| Q3 25 | $378.6M | $616.9M | ||
| Q2 25 | $377.6M | $633.7M | ||
| Q1 25 | $379.6M | $755.7M | ||
| Q4 24 | $395.7M | $761.3M | ||
| Q3 24 | $385.5M | $754.7M | ||
| Q2 24 | $389.1M | $815.4M | ||
| Q1 24 | $392.6M | $813.8M |
总资产
CTKB
RPAY
| Q4 25 | $461.5M | $1.2B | ||
| Q3 25 | $494.9M | $1.3B | ||
| Q2 25 | $493.3M | $1.4B | ||
| Q1 25 | $482.6M | $1.5B | ||
| Q4 24 | $499.5M | $1.6B | ||
| Q3 24 | $491.2M | $1.6B | ||
| Q2 24 | $483.7M | $1.5B | ||
| Q1 24 | $492.1M | $1.5B |
负债/权益比
CTKB
RPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $23.2M |
| 自由现金流率自由现金流/营收 | -2.9% | 29.6% |
| 资本支出强度资本支出/营收 | 1.6% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $90.7M |
8季度趋势,按日历期对齐
经营现金流
CTKB
RPAY
| Q4 25 | $-771.0K | $23.3M | ||
| Q3 25 | $-3.9M | $32.2M | ||
| Q2 25 | $108.0K | $33.1M | ||
| Q1 25 | $-125.0K | $2.5M | ||
| Q4 24 | $2.0M | $34.3M | ||
| Q3 24 | $13.2M | $60.1M | ||
| Q2 24 | $6.2M | $31.0M | ||
| Q1 24 | $4.0M | $24.8M |
自由现金流
CTKB
RPAY
| Q4 25 | $-1.8M | $23.2M | ||
| Q3 25 | $-4.6M | $32.1M | ||
| Q2 25 | $-1.5M | $33.0M | ||
| Q1 25 | $-974.0K | $2.4M | ||
| Q4 24 | $1.1M | $34.0M | ||
| Q3 24 | $12.2M | $59.8M | ||
| Q2 24 | $5.2M | $30.5M | ||
| Q1 24 | $3.4M | $24.7M |
自由现金流率
CTKB
RPAY
| Q4 25 | -2.9% | 29.6% | ||
| Q3 25 | -8.7% | 41.3% | ||
| Q2 25 | -3.2% | 43.6% | ||
| Q1 25 | -2.3% | 3.0% | ||
| Q4 24 | 1.9% | 43.5% | ||
| Q3 24 | 23.7% | 75.6% | ||
| Q2 24 | 11.0% | 40.7% | ||
| Q1 24 | 7.6% | 30.6% |
资本支出强度
CTKB
RPAY
| Q4 25 | 1.6% | 0.1% | ||
| Q3 25 | 1.3% | 0.2% | ||
| Q2 25 | 3.5% | 0.1% | ||
| Q1 25 | 2.0% | 0.2% | ||
| Q4 24 | 1.6% | 0.3% | ||
| Q3 24 | 2.0% | 0.3% | ||
| Q2 24 | 2.3% | 0.6% | ||
| Q1 24 | 1.3% | 0.1% |
现金转化率
CTKB
RPAY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |